Clinical Trial Update: Dendritic Cell Vaccine in HIV-1 Infection [Phase 1, Phase 2]

View source ↗

Summary

A dendritic cell vaccine trial in HIV infection has completed Phase 1/2 testing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Dendritic cell vaccine

Snippet

Sponsor: Hospital Clinic of Barcelona | Conditions: HIV Infections | Phase 1, Phase 2 | Status: COMPLETED